CA2531485C — Malonamide derivatives
Assigned to Merck Patent GmbH · Expires 2013-03-26 · 13y expired
What this patent protects
The present invention relates to malonamide derivatives of formula: (see above formula) wherein R6, R7 , R8, R9, R10, Ar1, Ar2, X, Y, p, q and r are as defined in claim 1, as inhibitors of raf-kinase and their use for the manufacture of a pharmaceutical composition.
USPTO Abstract
The present invention relates to malonamide derivatives of formula: (see above formula) wherein R6, R7 , R8, R9, R10, Ar1, Ar2, X, Y, p, q and r are as defined in claim 1, as inhibitors of raf-kinase and their use for the manufacture of a pharmaceutical composition.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.